vimarsana.com

Page 17 - குறிப்பு தொடர்பாக முன்னோக்கி பார்க்கிறது தகவல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedMen Reports Sequential Sales Increase in Third Quarter Fiscal Year 2021 Financial Results

Article content Third quarter revenue of $32.0 million, up 3.8% from the previous quarter adjusting for removal of MedMen NY Inc. from continuing operations Total Retail Revenue increase of 8.2% quarter-over-quarter, inclusive of New York and Arizona stores Total Retail Adjusted EBITDA increased to $8.5 million from $6.0 million quarter-over-quarter, for a 22.5% margin, and Total Retail Adjusted EBITDA from continuing operations increased to $7.4 million from $5.5 million quarter-over-quarter for a 23.3% margin LOS ANGELES MedMen Enterprises Inc. ( “MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a cannabis retailer with operations across the United States, today released its consolidated financial results for its third quarter fiscal 2021 ending March 27, 2021. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

Avicanna Announces Resignation of Board Member

Article content /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, May 07, 2021 (GLOBE NEWSWIRE) Avicanna Inc. (“ Avicanna” or the “ Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that Janet Giesselman has resigned from her role as an independent director of the Company to pursue other opportunities. The Company thanks Ms. Giesselman for her service and her contributions and wishes her all the best in her future endeavours. The board of directors of the Company is actively engaged in the search for a suitable candidate to fill the vacancy.

Avicanna Makes RHO Phyto™ Medical Cannabis Products

Avicanna Makes RHO Phyto™ Medical Cannabis Products Available In Canadian Hospital Pharmacies Through Agreement with Sunnybrook Hospital May 06, 2021 07:30 ET | Source: Avicanna Inc. Avicanna Inc. Toronto, CANADA Avicanna launches its initiative to supply major Canadian hospitals with its advanced RHO Phyto medical cannabis products supported by education, training, and patient support programs. Seven RHO Phyto products will be available for purchase at Sunnybrook Hospital ’s Odette Cancer Centre pharmacy by patients that have been issued a written order from an authorized health care practitioner. The collaborative program is aimed at setting a gold standard for medical cannabis care by establishing a complete cannabis consultation and dosing regimen provided through the expertise of Avicanna’s medical team and the Sunnybrook Hospital pharmacy team.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.